Alpha -1- Microglobulin (α1M) as an Early Biomarker in Renal Extrahepatic Manifestations of HCV-infection
NCT05276700 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 170
Last updated 2022-05-04
Summary
find the role of alpha one microglobulin (as an early renal tubular biomarker) to identify and evaluate the prevalence of early renal manifestations among patients with chronic HCV and compared these patients with HCV-negative healthy individuals
Conditions
- Renal Injury
- HCV
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Enas Alkareemy · Assiut University
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-15
- Primary Completion
- 2024-03-31
- Completion
- 2024-03-31
More Related Trials
-
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy
NCT02877199 ·Status: COMPLETED
-
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
NCT06470997 ·Status: RECRUITING
-
The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation
NCT04575077 ·Status: UNKNOWN
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
Immunological Measurement of Aspartate/Alanine Aminotransferase
NCT03562585 ·Status: COMPLETED
-
sgp130 in Chronic Human Liver Disease
NCT00770198 ·Status: COMPLETED
-
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation
NCT00701272 ·Status: UNKNOWN
-
Prevalence of Hepatitis c Virus Infection Among Rheumatological Patients
NCT03587714 ·Status: COMPLETED
-
Identification of Anti-HIF 1alpha Autoantibodies in Patients With Anorexia Nervosa and Characterization of Their Pathogenic Potential in Undernutrition-associated Hepatic Cytolysis
NCT06869590 ·Status: RECRUITING ·Phase: NA
-
Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis
NCT03693586 ·Status: COMPLETED
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease
NCT05865691 ·Status: RECRUITING
-
Liver Cirrhosis Network Cohort Study
NCT05740358 ·Status: ACTIVE_NOT_RECRUITING
-
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531 ·Status: WITHDRAWN
-
Hepatitis C in Clinically Discordant Hemophilic Siblings
NCT00007371 ·Status: COMPLETED
-
Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.
NCT00213707 ·Status: UNKNOWN
-
Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy
NCT03226717 ·Status: UNKNOWN
-
Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients
NCT06865859 ·Status: RECRUITING
-
Characterization of the Immunometabolic Signature in Long COVID-19.
NCT05758480 ·Status: COMPLETED ·Phase: NA
-
Autoimmune Hepatitis Cohort in China
NCT05785793 ·Status: RECRUITING
-
Is Negativity of Autoantibodies a Marker of Severity in Auto-immune Hepatitis?
NCT06761209 ·Status: RECRUITING
-
Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis
NCT04195724 ·Status: UNKNOWN ·Phase: NA
-
Serum Regucalcin Level and Chronic Hepatitis B
NCT05435599 ·Status: COMPLETED ·Phase: NA
-
sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis
NCT02924701 ·Status: ACTIVE_NOT_RECRUITING